Skip to main content
. 2014 Jan 24;9(1):e87129. doi: 10.1371/journal.pone.0087129

Figure 4. Reduced oncogenic properties in HNC-CSCs by ALA-PDT combined with cisplatin treatment.

Figure 4

(A) Invasion ability and (B) colony-forming ability in HNC-CSCs was examined after treatment with either ALA-PDT or cisplatin chemotherapy or both. *, p<0.05 ALA-PDT vs. Control; #, p<0.05 ALA-PDT +Cisplatin vs. ALA-PDT alone.